OpenEvidence, used by about 40% of US doctors, reached a $15 billion valuation
The clinical search engine got there on a previously unreported $250 million round led by Byers Capital and Andreessen Horowitz. The company says it is used across more than 10,000 hospitals and medical centers in the US, and that more than 40% of physicians log in daily to make decisions at the point of care. Annual revenue has passed $100 million.
Sources
- Business Insider, Business Insider report, (businessinsider.com)
- Forbes, “OpenEvidence Confirms It Has Raised An Additional $250 Million At A $15 Billion Valuation”, (forbes.com)
About this story
This story was posted on Instagram by @jarrus.tech on Sept. 26, 2026.
Spotted an error in this story? [email protected] · Instagram
Short link: thejarrus.com/en/h8-35
This story in Turkish: ABD’deki doktorların yaklaşık %40’ının kullandığı OpenEvidence 15 milyar dolar değerlemeye ulaştı
On the same topic
DeepMind-born drug discovery company Isomorphic Labs in funding talks at a $40-50 billion valuation
Isomorphic Labs, the DeepMind-born AI drug discovery company, is in early talks to raise money at a valuation of at least $40 billion, Bloomberg reported.
Stripe bought AI model marketplace OpenRouter for $8 billion. Nvidia was reportedly getting ready to make a last-minute counteroffer
According to The Information, Nvidia told OpenRouter it was prepared to make a counteroffer to Stripe’s deal, but it never submitted a formal bid.
Mecka, which pays people to wear body sensors and record their daily movements to sell data for humanoid robots, raised $60 million led by Sequoia
Mecka, which pays people to record everyday tasks with body sensors and supplies the motion data to robot makers, raised a $60 million Series B led by Sequoia.